¿À½ºÅ׿ÀÆùƾ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® ¸®Æ÷Æ® : À¯Çüº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Osteopontin Market Share, Size, Trends, Industry Analysis Report, By Type (Human, Rat, Cow, Others); By Application; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå : 1421828
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,981,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,389,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,796,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¿À½ºÅ׿ÀÆùƾ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 7¾ï 9,393¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ÇöÀçÀÇ ½ÃÀå ¿ªÇп¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¿À½ºÅ׿ÀÆùƾÀº ¿ìÀ¯¿¡¼­ ÃßÃâÇÑ ´Ü¹éÁú·Î À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯¿Í ¾Æ±â ¿µ¾ç º¸Ãæ¿¡ »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç »ó´çÇÑ ÀλêÈ­¸¦ °ÅÃÆ½À´Ï´Ù. À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯´Â ¾î¸°ÀÌ Áúº´ Ä¡·á ¹× ±âŸ ¿µ¾ç ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ¸ÂÃãÈ­ ÇÒ ¼ö ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â ¿À½ºÅ׿ÀÆùƾ ÇÔÀ¯ Á¦Ç°ÀÇ Ç°Áú°ú Ä¡·á È¿°ú¸¦ È®ÀÎÇÑ ÈÄ ¿À½ºÅ׿ÀÆùƾ ÇÔÀ¯ Á¦Ç°À» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¸ðȸ»çÀÎ °Ç°­ ¹× Çູ ±×·ì(H&H ±×·ì)¿¡ µû¸£¸é ÃÖ±Ù Áß±¹¿¡¼­ ½ÂÀÎµÈ ¹ÙÀÌ¿ÀŸÀÓÀÇ ½Å»ý¾Æ ºÐÀ¯ÀÇ ÁÖ¿ä ¼ººÐ Áß Çϳª´Â ¿ìÀ¯¿¡¼­ ÃßÃâÇÑ ¿À½ºÅ׿ÀÆùƾÀ¸·Î ¾Ë·ÁÁø ¶ôÅäÆùƾ(LPN)À̶ó°í ÇÕ´Ï´Ù. ÀÌ´Â ¿À½ºÅ׿ÀÆùƾ¿¡ ´ëÇÑ ¿¬±¸ Ȱµ¿ÀÌ ´õ¿í Ȱ¹ßÇØÁö°í ÀÖÀ½À» ÀǹÌÇϸç, ÇâÈÄ ¼ö³â°£ ¿À½ºÅ׿ÀÆùƾÀÇ È®Àå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±â¾÷ °³¿äÀº ¿À½ºÅ׿ÀÆùƾÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¸ðÀ¯¿Í °°ÀÌ ¿µ¾ç°¡ ³ôÀº ½ÅÁ¦Ç°À» »ý»êÇϱâ À§ÇØ ½Ã°£°ú ÀÚ±ÝÀ» ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¿À½ºÅ׿ÀÆùƾÀº ³ôÀº ¿µ¾ç ÇÔ·®°ú Àΰ£ÀÇ ´Ù¾çÇÑ °Ç°­ Àå¾Ö¸¦ Ä¡·áÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ÃÖ±Ù ¸î ÀÏ µ¿¾È Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. À¯´Ü¹éÁúÀÎ ¿À½ºÅ׿ÀÆùƾÀº ¸é¿ª ü°è, °Ç°­ÇÑ »À¿Í Ä¡¾Æ ¹ß´Þ¿¡ ±â¿©ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¿À½ºÅ׿ÀÆùƾÀÇ ÀÌÁ¡°ú ÇコÄÉ¾î ¹®Á¦¸¦ Ä¡·áÇÏ´Â µ¥ ÀÖÀ¸¸ç, ±× È¿´ÉÀ» °áÁ¤Çϱâ À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¼ö³â°£ ÀÌ ´Ü¹éÁú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, 2023³â ³×ÀÌóÁö¿¡ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é ¿À½ºÅ׿ÀÆùƾ°ú CD44 ºÐÀÚ´Â ¹ß¸ð¸¦ À¯¹ßÇÏ´Â Áß¿äÇÑ ºÐÀÚ·Î ¹àÇôÁ³½À´Ï´Ù. ºÐÀÚÀÔ´Ï´Ù. ÀÌ ¿¬±¸¸¦ ÅëÇØ ¹àÇôÁø ³»¿ëÀº ½ÃÀå¿¡¼­ »õ·Î¿î Á¦Ç°À» Çõ½ÅÇϱâ À§ÇÑ ¿¬±¸ Ȱµ¿¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ¿À½ºÅ׿ÀÆþƾ ½ÃÀå¿¡ »õ·Î¿î ¼ºÀå ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°ñ´Ù°øÁõÀÇ È®´ë´Â È¿°úÀûÀÎ Ä¡·á¹ýÀ» âÃâÇϰí ÀÇ·á¿ë Á¦Á¦¿¡ ¿À½ºÅ׿ÀÆùƾÀ» »ç¿ëÇϱâ À§ÇÑ Ãß°¡ ¿¬±¸ Ȱµ¿À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °ñ´Ù°øÁõÀº »À°¡ ¾àÇØÁö°í °ñÀý À§ÇèÀÌ ³ô¾ÆÁö´Â °ñÁúȯÀÔ´Ï´Ù. Àå±â°£ ´Ù·®ÀÇ À½ÁÖ´Â ½Åü°¡ »õ·Î¿î »À¸¦ »ý¼ºÇÏ°í ¸¶¸ðµÈ °ñ°Ý Á¶Á÷À» ´ëüÇÏ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. °ñ¹Ðµµ °¨¼Ò´Â °ñÀý°ú °ñ´Ù°øÁõÀÇ À§ÇèÀ» Áõ°¡½ÃÄÑ ÇâÈÄ ¼ö³â°£ ¿À½ºÅ׿ÀÆùƾ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀÔ´Ï´Ù.

¿À½ºÅ׿ÀÆùƾ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿¬±¸ÀÚµé°ú Á¦¾àȸ»çµéÀÌ È¿°úÀûÀÎ Á¦Á¦¸¦ °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¹Ç·Î ÀÎü¿ë ºÎ¹®Àº ºü¸£°Ô ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.

ÀÇ·á¿ë ºÎ¹®Àº ÀǾàǰ ¹× ÀÇ·á¿ë Ä¡·áÁ¦¿¡ ƯȭµÈ °úÇÐÀû ¿¬±¸ Áõ°¡·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ºÏ¹Ì´Â »À °ü·Ã ÁúȯÀ¸·Î ÀÎÇØ °¡Àå Å« ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´Àº ±â¾÷ÀÌ ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ÁؼöÇϰí Áö¿ª ÁÖ¹Îµé »çÀÌ¿¡¼­ ½Å·Ú¸¦ ½×¾Æ°¡°í ÀÖÀ¸¹Ç·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¿À½ºÅ׿ÀÆùƾ ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¿À½ºÅ׿ÀÆùƾ ½ÃÀå, À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ¿À½ºÅ׿ÀÆùƾ ½ÃÀå, ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ¿À½ºÅ׿ÀÆùƾ ½ÃÀå, Áö¿ªº°

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global osteopontin market size is expected to reach USD 793.93 million by 2032, according to a new study by Polaris Market Research. The report "Osteopontin Market Share, Size, Trends, Industry Analysis Report, By Type (Human, Rat, Cow, Others); By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Osteopontin is a protein derived from cow's milk that can be used in infant formula and baby nutrition regimens and has undergone considerable phosphorylation. Manufacturers are coming up with new product formulations to create high-quality infant formulas that can be customized to treat a child's illnesses and satisfy other nutritional needs. Governments are supporting the products with osteopontin after checking their quality and effectiveness in curing.

According to parent company Health and Happiness Group (H&H Group), one of the main ingredients in the recently approved newborn formula by Biostime in China is lactopontin (LPN), also known as osteopontin from the cow's milk. This is demonstrating the rise in further research activities about osteopontin, fueling its expansion in the coming years. Manufacturing companies are investing time and funds to create new products with a higher nutritional profile, like breast milk, which has osteopontin as a major ingredient.

Osteopontin has gained traction in recent days owing to its higher nutritional content and its ability to treat various health difficulties in humans. It is believed that the milk protein osteopontin contributes to the development of the immune system, healthy bones, and teeth. Growing research and development activities to determine the benefits of osteopontin and its effectiveness in treating health care issues are driving the demand for this protein in the coming years. According to the study, which was published in the journal Nature in 2023, osteopontin & CD44 molecules are crucial for triggering hair growth. This revelation from the study will further create new growth opportunities for the osteopontin market by fueling research activities to innovate new products in the marketplace.

Growing osteoporosis is driving further research activities to create effective therapies and use osteopontin in medical formulations. Osteoporosis is a bone disease that results in weakened bones and a higher risk of bone fractures. Heavy drinking over time might affect the body's capacity to develop new bones and replace worn-out skeletal tissues. Due to the decreased bone density, this raises the risk of bone fractures and osteoporosis, driving demand for osteopontin in the coming years.

Osteopontin Market Report Highlights

Human segment will grow at rapid pace, due to the rise in researchers and pharmaceutical companies' efforts to create effective product formulations.

Medical segment accounted for the largest market share owing to the growing scientific studies specializing in pharmaceutical and medical therapy formulations.

North America is projected to register the largest growth rate, owing to the bone-related diseases in the region.

Europe is expected to have the fastest growth owing to companies following stringent regulations and building trust among the people in the region.

The global players include: Abnova, ACROBiosystems, Arla Foods Ingredients, BioLegend, MilliporeSigma & MyBioSource.

Polaris Market Research has segmented the osteopontin market report based on type, application, and region:

Osteopontin, Type Outlook (Revenue - USD Million, 2019 - 2032)

Osteopontin, Application Outlook (Revenue - USD Million, 2019 - 2032)

Osteopontin, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Osteopontin Market Insights

5. Global Osteopontin Market, by Type

6. Global Osteopontin Market, by Application

7. Global Osteopontin Market, by Geography

8. Competitive Landscape

9. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â